Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Increased Lamin A expression and heterochromatin changes in the hippocampus at early Alzheimer’s disease stages
Aging, Dementia, and Behavioral Neurology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
10-004

To compare the presence of Lamin A, p-Tau and the heterochromatin marker H4K20me3 in hippocampal sections from control and AD brains.

It has been proposed that Alzheimer’s disease (AD) is an aging-associated laminopathy. In Drosophila melanogaster, structural Lamin B dysfunction mediates neurodegeneration linked to Tau protein. In human cells, Lamin A interacts with genome through lamin-associated domains (LADs) and regulates gene expression, but it's poorly expressed in neurons, and its participation in AD is unknown.

Paraffin sections obtained from control and AD brains at stages I-II, III-IV, and V-VI were processed for immunohistochemistry and immunofluorescence. The following nuclear, nucleolar, and heterochromatin specific markers were tested in the hippocampal CA1 and CA3 regions: p-Tau, Lamin A, B23 (nucleophosmin) and H4K20me3.

At initial AD stages(I-II), p-Tau leaves neuronal nuclei and accumulates in the cytoplasm leading to neurofibrillary tangles (AD stages III-VI). Simultaneously, a marked increase of Lamin A expression and H4K20me3 in LADs is observed in hippocampal pyramidal neurons.

Anomalous Lamin A expression and epigenetic changes that modify the heterochromatin structure are critical events at the beginning of neurodegeneration.

Authors/Disclosures
Ildefonso Rodriguez-Leyva, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Facultad de Medicina, Universidad Autonoma de San Luis Potosi)
PRESENTER
Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Maria E. Jimenez-Capdeville, PhD (Universidad De San Luis Potosi, Mexico) Dr. Jimenez-Capdeville has nothing to disclose.